~~<i id='5C2AE0176D'><strike id='5C2AE0176D'><tt id='5C2AE0176D'><pre id='5C2AE0176D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

author：entertainment 2025-08-19 20:45:20 - browse：5

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Study: Hearing aids may slow cognitive decline in those at risk

knowledge

hotspot

explore

focus

leisure time

MandyCohen,seenhereduringabriefinginRaleigh,servedasNorthCarolina’ssecretaryofhealthandhumanservices

WSS

Blood tests recalled over risk of missed heart attack diagnosis

Mike Pence clashes with Tucker Carlson in Iowa

Johnson & Johnson sues to stop Medicare negotiation

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Manchin plays down potential 3rd

leisure time

leisure time

knowledge

Medical records are filled with copy

Biden administration sends mixed signals on US soldier who crossed into North Korea

At least 13 dead in Texas as scorching temps continue

What we know about the American soldier detained in North Korea

Walensky prepares to leave CDC — and Congress — behind

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

How to save PrEP access — and even expand it

Does aspartame cause cancer? What new WHO guidance says

hotspot

FDA seeking to stop procedures at two unregulated stem cell clinics

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

What we know about the American soldier detained in North Korea

Can CDC director Mandy Cohen drive consensus in Washington?

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Blood tests recalled over risk of missed heart attack diagnosis

hotspot

explore

focus

leisure time